NABI BIOPHARMACEUTICALS Aktie

1,28 EUR -0,3123%

Zu Ihrem Onlinebroker

kaufen verkaufen

NABI BIOPHARMACEUTICALS Aktienkurs : 25.05. ( 15 Min. verzögert)
1,28 € Letzter Kurs	-0,31% Veränderung	1,28 € Vortag	1,28 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
1,28 - 1,28 Tag	3,99 - 1,19 52 Wochen	0 Tag	270 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

NABI BIOPHARMACEUTICALS Aktie…

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

25.05.

Prima stays true to its Aussie roots

... Australia's investment pool for biotechnology companies after Biota last month revealed plans to delist its Australian shares and merge with Nasdaq-listed Nabi Biopharmaceuticals to help it access ...
21.05.

Shareholder Update - Proposal to create Biota Pharmaceuticals with NASDAQ listing

The proposal involves the merger of Biota Holdings with US company, Nabi Biopharmaceuticals (Nabi), which is already listed on NASDAQ. The merged company will consist of Biota's existing assets, an additional US$54 million...

16.05.

Biota chops its losses in half

Revenue from continuing operations rose to $14.9m, from $10.6m, and research expenses fell to $11.9m from $14.6m. In April, Biota and Nabi Biopharmaceuticals Inc agreed to merge and form Biota Pharmaceuticals, which will be listed on the Nasdaq index ...
16.05.

Antares Pharma appoints LeRoux Jooste SVP pharma sales and marketing

Previously, he was with Nabi Biopharmaceuticals as senior VP global sales and marketing after serving as chief operating officer of Aton Pharma. Earlier in his career...
16.05.

Biota halves losses over nine months

In April, Biota and Nabi Biopharmaceuticals Inc agreed to merge and form Biota Pharmaceuticals, which will be listed on the Nasdaq index in the US and...